Literature DB >> 1563808

Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I.

J N Walterspiel1, S Ashkenazi, A L Morrow, T G Cleary.   

Abstract

Patients with diarrhea due to strains of enterohemorrhagic Escherichia coli (EHEC) (e. g. O157:H7) might be at a higher risk of developing hemolytic uremic syndrome when treated with antimicrobial agents. It has been suggested that this might be due to an increase of release or production of vero or shiga-like toxin from such organisms, possibly as a stress response to antimicrobial agents. The aim of this study was to detect such increases in extracellular toxin in vitro with a newly developed method that exposed EHEC to high sublethal concentrations followed by a recovery phase at progressively lower concentrations. Five strains of EHEC were exposed to continuously changing concentrations of ciprofloxacin, co-trimoxazole, cefixime and tetracycline. The amount of free shiga-like toxin I (SLT-I) released was compared to the amount released from inocula that were not exposed to antibiotics. There were significant differences between the five EHEC strains in the amount of toxin detected after exposure to antimicrobial agents (p less than 0.001). Equally important was the type of antibiotic (p less than 0.001), with ciprofloxacin inducing the largest increase ranging from 169 to 436%, followed by co-trimoxazole, cefixime and tetracycline. In addition, the increases in free toxin correlated with the concentration of the antibiotics (p less than 0.001). The association between antibiotic-induced increases in SLT-I produced by strains of EHEC and certain classes of antibiotics might influence the analysis of future epidemiological studies on risk factors for HUS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563808     DOI: 10.1007/bf01704889

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  22 in total

1.  Electron microscopy of chloramphenicol-treated Escherichia coli.

Authors:  C Morgan; H S Rosenkranz; H S Carr; H M Rose
Journal:  J Bacteriol       Date:  1967-06       Impact factor: 3.490

Review 2.  The SOS regulatory system of Escherichia coli.

Authors:  J W Little; D W Mount
Journal:  Cell       Date:  1982-05       Impact factor: 41.582

3.  Effects of subminimal inhibitory concentrations of ampicillin, chloramphenicol, and nitrofurantoin on the attachment of Escherichia coli to human uroepithelial cells in vitro.

Authors:  T Sandberg; K Stenqvist; C Svanborg-Edén
Journal:  Rev Infect Dis       Date:  1979 Sep-Oct

4.  Relative morphological effects induced by cefoxitin and other beta-lactam antibiotics in vitro.

Authors:  S B Zimmerman; E O Stapley
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

5.  DNA probes for Shiga-like toxins I and II and for toxin-converting bacteriophages.

Authors:  J W Newland; R J Neill
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

6.  Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations.

Authors:  A T Pavia; C R Nichols; D P Green; R V Tauxe; S Mottice; K D Greene; J G Wells; R L Siegler; E D Brewer; D Hannon
Journal:  J Pediatr       Date:  1990-04       Impact factor: 4.406

7.  Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance.

Authors:  S M Ostroff; J M Kobayashi; J H Lewis
Journal:  JAMA       Date:  1989-07-21       Impact factor: 56.272

8.  Lincomycin increases synthetic rate and periplasmic pool size for cholera toxin.

Authors:  M H Levner; C Urbano; B A Rubin
Journal:  J Bacteriol       Date:  1980-07       Impact factor: 3.490

9.  Effects of subminimal inhibitory concentrations of antibiotics on adhesiveness of Escherichia coli in vitro.

Authors:  K Vosbeck; H Handschin; E B Menge; O Zak
Journal:  Rev Infect Dis       Date:  1979 Sep-Oct

10.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

View more
  43 in total

1.  Escherichia coli infections and hemolytic-uremic syndrome.

Authors:  N Cimolai
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

2.  E. coli, antibiotics and hemolytic-uremic syndrome in children.

Authors:  D Farquhar
Journal:  CMAJ       Date:  2000-08-22       Impact factor: 8.262

Review 3.  Bacteriophage control of bacterial virulence.

Authors:  Patrick L Wagner; Matthew K Waldor
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

4.  Escherichia coli O157:H7, other verotoxin-producing E coli and the hemolytic uremic syndrome in childhood.

Authors:  P C Rowe
Journal:  Can J Infect Dis       Date:  1995-03

5.  A Conserved Structural Motif Mediates Retrograde Trafficking of Shiga Toxin Types 1 and 2.

Authors:  Andrey S Selyunin; Somshuvra Mukhopadhyay
Journal:  Traffic       Date:  2015-11-02       Impact factor: 6.215

6.  Comparison of the BD MAX® Enteric Bacterial Panel assay with conventional diagnostic procedures in diarrheal stool samples.

Authors:  L Knabl; I Grutsch; D Orth-Höller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-13       Impact factor: 3.267

7.  In vivo transduction of an Stx-encoding phage in ruminants.

Authors:  Nancy A Cornick; Amy F Helgerson; Volker Mai; Jennifer M Ritchie; David W K Acheson
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

Review 8.  Enteropathogenic and enterohemorrhagic Escherichia coli virulence gene regulation.

Authors:  Jay L Mellies; Alex M S Barron; Anna M Carmona
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

Review 9.  Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.

Authors:  Stephen B Freedman; Jianling Xie; Madisen S Neufeld; William L Hamilton; Lisa Hartling; Phillip I Tarr; Alberto Nettel-Aguirre; Anderson Chuck; Bonita Lee; David Johnson; Gillian Currie; James Talbot; Jason Jiang; Jim Dickinson; Jim Kellner; Judy MacDonald; Larry Svenson; Linda Chui; Marie Louie; Martin Lavoie; Mohamed Eltorki; Otto Vanderkooi; Raymond Tellier; Samina Ali; Steven Drews; Tim Graham; Xiao-Li Pang
Journal:  Clin Infect Dis       Date:  2016-02-24       Impact factor: 9.079

Review 10.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.